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valorisaTion paragraph To The phd Thesis
Towards a testing strategy for the identification of respiratory sensitizing chemicals
Occupational asthma, asthma obtained through exposure to a chemical at the workplace, 
is a prevalent condition among workers. Compared to most other types of work related 
diseases, occupational asthma has very severe consequences for a worker. When 
a worker is exposed and sensitized to a specific chemical, the worker usually is not 
able to come near the workplace and potentially not even near the building itself. 
Compared to for example a work-related injury such as breaking a leg at a construction 
site, the socioeconomic consequences are much harsher for occupational asthma. It is 
therefore highly desirable to identify chemicals that can cause occupational asthma 
and take precautionary measures to prevent exposure to those chemicals. The problem 
is that prospective identification of these chemicals is currently not possible due to 
the lack of widely accepted testing methods (both animal and animal-free methods). In 
addition, with the current mindset of replacing, reducing and refining animal testing, 
the challenge to develop a method to identify these chemicals has not become easier. 
Nevertheless, this thesis aims to evaluate and develop different testing methods that are 
specifically designed to identify chemicals that cause occupational asthma. 
The first type of methods evaluated are (quantitative) structure activity relationship 
models (QSARs). These in silico methods provide predictions on respiratory 
sensitization potential of chemicals based on their chemical structure. They roughly 
apply two different approaches to interpret the query chemical. Some in silico models 
evaluate the query chemical structure and search for similarities between the query 
chemical and a database of chemical structures known to cause occupational asthma. 
The other type searches the query chemical structure for specific chemical subdomains 
known to be protein reactive. Both applications are deemed valid, although a slight 
emphasis on the latter approach can be found in recent publications regarding 
respiratory sensitization as protein binding is known to be the molecular initiating event 
of respiratory sensitization that leads to occupational asthma. Further development 
of such in silico models, or at least, more insight in the actual chemistry involved in 
respiratory sensitization can result in highly efficient (time-wise and money-wise) 
tools for this toxicological end-point.
The second method evaluated in this thesis is the Direct Peptide Reactivity Assay 
(DPRA). This method measures the binding potential of chemicals to heptapeptides 
that mimic human proteins to which chemicals can bind. This method was originally 
designed to identify chemicals that cause skin sensitization, but it can also be applied to 
the field of respiratory sensitization as covalent binding between chemicals and proteins 
is the molecular initiating event for respiratory sensitization as well. The  published 
methodology was evaluated and improved upon to increase the reliability of predictions 
and to obtain information on reaction chemistry. This information can be directly 
used by QSAR developers to improve their in silico models. In addition, the DPRA 
can provide predictions for chemicals that are (currently) not able to be predicted by 
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QSARs due to issues in their applicability domain. Together, QSARs and the DPRA 
can provide a chemically relevant reliable prediction on the respiratory sensitization 
potential of chemical. However, the process that ultimately leads to occupational 
asthma involves many biological processes as well. 
The third method developed in this thesis specifically addresses a small part of these 
biological processes. Specifically, an in vitro method was developed based on the first 
cell layer a chemical encounters when it enters the lungs, the epithelial lung barrier. 
It was found that several different genes were affected by respiratory sensitizers that 
are shown to be involved in the process of respiratory sensitization. However, these 
processes are mostly associated with the barrier function of the cells themselves, and 
less involved in immunological processes. Although this is not a major issue in terms 
of predictivity and biological relevance, it can be argued that an in vitro model based 
on more immunological relevant genes might be more appropriate, especially when it 
comes to applying the obtained gene set for a patent. 
This thesis shows that by combining the abovementioned methods for the prediction 
of respiratory sensitization potential of chemicals, a prediction accuracy higher than any 
individual method can be obtained. This application, generally called a testing strategy, 
is becoming to be more relevant in the scientific community in general. The general 
consensus is that focus should shift to the development of these types of strategies 
instead of focusing solely on development of individual methods. Obviously, testing 
strategies only function when individual methods are combined, so sufficient attention 
should be given to that aspect as well. Increasing predictive performance of a model 
or strategy for respiratory sensitization is required as it will lead to better protection 
of workers. It is also important for industries working with potential respiratory 
sensitizers as it is more economical to adapt a manufacturing process beforehand than 
afterwards. One specific branch that could benefit from the developments in testing 
strategies for respiratory sensitization is contract research laboratories, as they could 
provide a prediction service based on a respiratory sensitizer testing strategy for 
affected industries.
It is concluded in this thesis that combining different individual testing methods 
is the way forward to allow for fast evaluation of chemicals that can potentially cause 
occupational asthma. This is deemed highly necessary as many workers are affected 
by this disease and therefore the impact on society is high. With the advancement of 
individual methods, the development of a knowledgebase regarding this toxicological 
endpoint in the form of an adverse outcome pathway, and the insights that the individual 
methods can be combined according to the different aspects of the AOP, it is likely 
that a strategy for the prospective identification of low molecular weight respiratory 
sensitizers is to be validated and accepted.
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